Healthcare provider profile · identity verified

Cydney Mortensen, PA

Physician Assistant · WEST JORDAN, UT · NPI 1992766901

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	227	52
Oxycodone Hcl	Oxycodone Hcl	227	44
Potassium Chloride	Potassium Chloride	226	50
Eliquis	Apixaban	206	25
Gabapentin	Gabapentin	170	29
Lisinopril	Lisinopril	144	34
Trazodone Hcl	Trazodone Hcl	135	28
Furosemide	Furosemide	130	36
Levothyroxine Sodium	Levothyroxine Sodium	119	22
Amlodipine Besylate	Amlodipine Besylate	109	24
Baclofen	Baclofen	85	suppressed
Ondansetron Odt	Ondansetron	82	31
Sertraline Hcl	Sertraline Hcl	80	15
Pregabalin	Pregabalin	79	12
Gentamicin Sulfate	Gentamicin Sulfate	76	suppressed
Jardiance	Empagliflozin	75	suppressed
Clonidine Hcl	Clonidine Hcl	73	18
Clonazepam	Clonazepam	69	16
Spironolactone	Spironolactone	67	14
Carvedilol	Carvedilol	63	12
Warfarin Sodium	Warfarin Sodium	63	suppressed
Metformin Hcl	Metformin Hcl	62	16
Losartan Potassium	Losartan Potassium	59	14
Sodium Chloride	0.9 % Sodium Chloride	59	22
Tamsulosin Hcl	Tamsulosin Hcl	59	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	58	14
Prednisone	Prednisone	57	22
Buspirone Hcl	Buspirone Hcl	56	suppressed
Duloxetine Hcl	Duloxetine Hcl	56	15
Donepezil Hcl	Donepezil Hcl	55	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	55	13
Methenamine Hippurate	Methenamine Hippurate	54	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	52	suppressed
Metoprolol Succinate	Metoprolol Succinate	46	16
Levofloxacin	Levofloxacin	45	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	45	17
Diclofenac Sodium	Diclofenac Sodium	44	17
Tramadol Hcl	Tramadol Hcl	44	21
Celecoxib	Celecoxib	43	12
Bupropion Xl	Bupropion Hcl	42	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	42	suppressed
Bumetanide	Bumetanide	41	suppressed
Alendronate Sodium	Alendronate Sodium	40	suppressed
Morphine Sulfate Er	Morphine Sulfate	37	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	16
Lamotrigine	Lamotrigine	34	suppressed
Mirtazapine	Mirtazapine	33	11
Xarelto	Rivaroxaban	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Movantik	Naloxegol Oxalate	31	suppressed
Cephalexin	Cephalexin	30	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	30	13
Metoclopramide Hcl	Metoclopramide Hcl	30	suppressed
Omeprazole	Omeprazole	30	15
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Torsemide	Torsemide	29	suppressed
Trulicity	Dulaglutide	29	suppressed
Albuterol Sulfate	Albuterol Sulfate	28	16
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Clindamycin Hcl	Clindamycin Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Topiramate	Topiramate	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Fluconazole	Fluconazole	24	11
Allopurinol	Allopurinol	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Azithromycin	Azithromycin	22	12
Metoprolol Tartrate	Metoprolol Tartrate	22	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	22	suppressed
Nystatin	Nystatin	21	11
Albuterol Sulfate Hfa	Albuterol Sulfate	20	12
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Olanzapine	Olanzapine	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Insulin Lispro	Insulin Lispro	19	suppressed
Alprazolam	Alprazolam	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	suppressed
Enulose	Lactulose	17	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Midodrine Hcl	Midodrine Hcl	15	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Carvedilol Er	Carvedilol Phosphate	14	suppressed
Lithium Carbonate	Lithium Carbonate	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Vascepa	Icosapent Ethyl	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Dapagliflozin	Dapagliflozin Propanediol	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Meropenem-0.9% Nacl	Meropenem-0.9% Sodium Chloride	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Famotidine	Famotidine	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Misoprostol	Misoprostol	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Primidone	Primidone	11	suppressed
Temazepam	Temazepam	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error